These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9767376)

  • 1. Peroxynitrite generation might explain elevated glutamate and aspartate levels in multiple sclerosis cerebrospinal fluid.
    Gurwitz D; Kloog Y
    Eur J Clin Invest; 1998 Sep; 28(9):760-1. PubMed ID: 9767376
    [No Abstract]   [Full Text] [Related]  

  • 2. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
    Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
    Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in neurotransmitters in multiple sclerosis.
    Barkhatova VP; Zavalishin IA; Askarova LSh; Shavratskii VKh; Demina EG
    Neurosci Behav Physiol; 1998; 28(4):341-4. PubMed ID: 9762701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
    Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE
    Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory amino acid levels in cerebrospinal fluid of patients with infantile spasms.
    Ince E; Karagöl U; Deda G
    Acta Paediatr; 1997 Dec; 86(12):1333-6. PubMed ID: 9475311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of cerebrospinal fluid glutamate in Rett syndrome.
    Lappalainen R; Riikonen RS
    Pediatr Neurol; 1996 Oct; 15(3):213-6. PubMed ID: 8916158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic N-methyl-D-aspartate receptor activation inhibits neurotransmitter release through nitric oxide formation in rat hippocampal nerve terminals.
    Sequeira SM; Malva JO; Carvalho AP; Carvalho CM
    Brain Res Mol Brain Res; 2001 Apr; 89(1-2):111-8. PubMed ID: 11311981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxynitrite formation within the central nervous system in active multiple sclerosis.
    Cross AH; Manning PT; Keeling RM; Schmidt RE; Misko TP
    J Neuroimmunol; 1998 Aug; 88(1-2):45-56. PubMed ID: 9688323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in nitrite and nitrate (NO2-/NO3-) levels in cerebrospinal fluid of patients with multiple sclerosis.
    Yamashita T; Ando Y; Obayashi K; Uchino M; Ando M
    J Neurol Sci; 1997 Dec; 153(1):32-4. PubMed ID: 9455975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of spinal N-methyl-D-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3,5-monophosphate/glutamate release cascade in nociceptive signaling.
    Kawamata T; Omote K
    Anesthesiology; 1999 Nov; 91(5):1415-24. PubMed ID: 10551594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly elevated nitrate/nitrite levels in the cerebrospinal fluid of children with progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome).
    Vanhatalo S; Riikonen R
    Epilepsia; 2000 Jun; 41(6):705-8. PubMed ID: 10840402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CSF glutamate following injection of ALS immunoglobulins.
    La Bella V; Goodman JC; Appel SH
    Neurology; 1997 May; 48(5):1270-2. PubMed ID: 9153455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
    Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
    J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Gua Lou Gui Zhi decoction on focal cerebral ischemia-reperfusion injury through regulating the expression of excitatory amino acids and their receptors.
    Chen X; Li H; Huang M; Huang M; Xu W; Chu K; Chen L; Zhang Y
    Mol Med Rep; 2014 Jul; 10(1):248-54. PubMed ID: 24788947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutamate neurotransmission and calcium metabolism in cerebral ischaemia and under normal conditions].
    Gusev EI; Skvortsova VI
    Usp Fiziol Nauk; 2002; 33(4):80-93. PubMed ID: 12449809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.
    Svenningsson A; Petersson AS; Andersen O; Hansson GK
    Neurology; 1999 Nov; 53(8):1880-2. PubMed ID: 10563648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How chronic administration of benzodiazepines leads to unexplained chronic illnesses: A hypothesis.
    LaCorte S
    Med Hypotheses; 2018 Sep; 118():59-67. PubMed ID: 30037616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis.
    Giovannoni G
    Mult Scler; 1998 Feb; 4(1):27-30. PubMed ID: 9532589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome.
    Ikeda M; Sato I; Matsunaga T; Takahashi M; Yuasa T; Murota S
    Intern Med; 1995 Aug; 34(8):734-7. PubMed ID: 8563111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis.
    de Bustos F; Navarro JA; de Andrés C; Molina JA; Jiménez-Jiménez FJ; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Martínez-Salio A; Arenas J
    Eur Neurol; 1999 Jan; 41(1):44-7. PubMed ID: 9885328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.